News

Soleno Therapeutics to Present at the 30th Annual Oppenheimer Healthcare Conference

March 11, 2020

REDWOOD CITY, Calif. , March 11, 2020 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2019 Financial Results

March 04, 2020

REDWOOD CITY, Calif. , March 04, 2020 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More

Soleno Therapeutics Completes Target Enrollment in Ongoing DESTINY PWS Phase III Trial of DCCR in Prader Willi Syndrome

January 06, 2020

Company Continues to Expect Top-line Data in First Half of 2020 REDWOOD CITY, Calif. , Jan. 06, 2020 (GLOBE ...

Read More
Soleno – Home